--- title: "14:06 ETSHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--VYNE, MASI, IBCP, and HCBN" type: "News" locale: "en" url: "https://longbridge.com/en/news/281409785.md" description: "Class Action Attorney Juan Monteverde is investigating mergers involving VYNE Therapeutics, Masimo Corporation, Independent Bank Corporation, and HCB Financial Corp. VYNE shareholders will own 3% of the merged entity with Yarrow Bioscience. Masimo shareholders will receive $180 per share from Danaher Corporation. HCB shareholders will get 1.5900 shares of Independent stock and $17.51 per HCB share. The shareholder vote for Masimo is set for May 1, 2026. Monteverde & Associates PC has a strong track record in recovering funds for shareholders." datetime: "2026-04-01T18:07:17.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/281409785.md) - [en](https://longbridge.com/en/news/281409785.md) - [zh-HK](https://longbridge.com/zh-HK/news/281409785.md) --- # 14:06 ETSHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--VYNE, MASI, IBCP, and HCBN , /PRNewswire/ -- **Class Action Attorney** Juan Monteverde **with** Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a **Top 50** **Firm** in the 2025 ISS Securities Class Action Services Report. We are headquartered at the **Empire State Building** in New York City and are investigating - **VYNE Therapeutics Inc. (NASDAQ:** **VYNE****)** related to its merger with Yarrow Bioscience, Inc. Upon completion of the proposed transaction, VYNE shareholders are expected to own 3% of the combined company. **Click here for more information** **https://monteverdelaw.com/case/vyne-therapeutics-inc/****. It is free and there is no cost or obligation to you.** - **Masimo Corporation (NASDAQ:** **MASI****)** **r**elated to its sale to Danaher Corporation. Under the terms of the proposed transaction, Masimo shareholders will receive $180.00 per share in cash. **ACT NOW. The Shareholder Vote is scheduled for May 1, 2026.** **Click here for more information** **https://monteverdelaw.com/case/masimo-corporation/****. It is free and there is no cost or obligation to you.** - **Independent Bank Corporation (NASDAQ:** **IBCP****)** related to its sale to HCB Financial Corp. Under the terms of the proposed transaction, HCB shareholders are expected to receive 1.5900 shares of Independent common stock and $17.51 for each share of HCB common stock. **Click here for more information** **https://monteverdelaw.com/case/independent-bank-corporation/****. It is free and there is no cost or obligation to you.** - **HCB Financial Corp. (OTCPK:** **HCBN****)** related to its merger with Independent Bank Corporation. Under the terms of the proposed transaction, HCB shareholders are expected to receive 1.5900 shares of Independent common stock and $17.51 for each share of HCB common stock. **Click here for more info** **https://monteverdelaw.com/case/hcb-financial-corp/****.** **It is free and there is no cost or obligation to you.** **NOT ALL LAW FIRMS ARE THE SAME.** Before you hire a law firm, you should talk to a lawyer and ask: 1. Do you file class actions and go to Court? 2. When was the last time you recovered money for shareholders? 3. What cases did you recover money in and how much? **About Monteverde & Associates PC** Our firm litigates and has recovered money for shareholders…and we do it from our offices in the Empire State Building. We are a national class action securities firm with a successful track record in trial and appellate courts, including the U.S. Supreme Court. **No company, director or officer is above the law.** If you own common stock in the above listed company and have concerns or wish to obtain additional information free of charge, please visit our **website** or contact Juan Monteverde, Esq. either via e-mail at **\[email protected\]** or by telephone at (212) 971-1341. Contact: Juan Monteverde, Esq. MONTEVERDE & ASSOCIATES PC **The Empire State Building** 350 Fifth Ave. Suite 4740 New York, NY 10118 United States of America \[email protected\] Tel: (212) 971-1341 Attorney Advertising. (C) 2026 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter. SOURCE Monteverde & Associates PC ### Related Stocks - [XHE.US](https://longbridge.com/en/quote/XHE.US.md) - [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md) - [ARWR.US](https://longbridge.com/en/quote/ARWR.US.md) - [LABU.US](https://longbridge.com/en/quote/LABU.US.md) - [XLV.US](https://longbridge.com/en/quote/XLV.US.md) - [FBT.US](https://longbridge.com/en/quote/FBT.US.md) - [BIB.US](https://longbridge.com/en/quote/BIB.US.md) - [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md) - [MASI.US](https://longbridge.com/en/quote/MASI.US.md) - [IBB.US](https://longbridge.com/en/quote/IBB.US.md) - [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md) - [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md) - [IHI.US](https://longbridge.com/en/quote/IHI.US.md) ## Related News & Research - [Shah Capital Management Will Vote ‘No' Across Five Proposals On Novavax's June 18 Ballot - SEC Filing](https://longbridge.com/en/news/286565204.md) - [Liminatus Pharma Announces Proposed Merger with InnocsAI to Expand Oncology Cell Therapy Pipeline | LIMN Stock News](https://longbridge.com/en/news/287218720.md) - [Jenscare’s LuX-Valve Plus Shows Strong One-Year Results in Large Annulus Tricuspid Patients](https://longbridge.com/en/news/287144318.md) - [Northwestern Mutual Wealth Management Co. Purchases 100,968 Shares of Medpace Holdings, Inc. $MEDP](https://longbridge.com/en/news/286744952.md) - [Edwards Lifesciences CVP, Strategy/Corp Development Sold Shares Worth Over $1.4M](https://longbridge.com/en/news/286822028.md)